Product Code: ETC417036 | Publication Date: Oct 2022 | Updated Date: Feb 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
United Arab Emirates (UAE) Buprenorphine market currently, in 2023, has witnessed an HHI of 9535, Which has decreased substantially as compared to the HHI of 10000 in 2017. The market is moving towards Highly concentrated. Herfindahl index measures the competitiveness of exporting countries. The range lies from 0 to 10000, where a lower index number represents a larger number of players or exporting countries in the market while a large index number means fewer numbers of players or countries exporting in the market.
Buprenorphine, a medication used to treat opioid addiction, has gained prominence in the UAE healthcare landscape. The government has taken measures to combat substance abuse, leading to an expanding market for buprenorphine as part of addiction treatment programs.
The buprenorphine market in the UAE is witnessing notable growth due to efforts to combat opioid addiction. Buprenorphine, known for its effectiveness in opioid replacement therapy, has gained traction in the country`s healthcare system. Government initiatives and awareness campaigns aimed at addressing addiction-related issues have further propelled the market.
The buprenorphine market faces challenges related to regulatory compliance. Given its use in opioid addiction treatment, strict regulations govern its production, prescription, and distribution. Navigating these regulatory frameworks while ensuring access for those in need remains a complex issue for stakeholders in this market.
The UAE Buprenorphine market encounters challenges related to stigma and addiction treatment infrastructure. Buprenorphine is used in medication-assisted treatment for opioid addiction. Addressing societal stigma surrounding addiction and establishing robust treatment infrastructures are crucial for the effective utilization of buprenorphine in the UAE.
Within the UAE pharmaceutical landscape, the Buprenorphine market features key players committed to substance abuse treatment. Mundipharma, a multinational pharmaceutical company, offers Buprenorphine products under the brand name Temgesic. This company plays a vital role in providing effective addiction treatment solutions in the UAE.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Buprenorphine Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Buprenorphine Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Buprenorphine Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Arab Emirates (UAE) Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Arab Emirates (UAE) Buprenorphine Market Trends |
6 United Arab Emirates (UAE) Buprenorphine Market, By Types |
6.1 United Arab Emirates (UAE) Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Buprenorphine Market Revenues & Volume, By Application, 2021-2031F |
6.1.3 United Arab Emirates (UAE) Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.4 United Arab Emirates (UAE) Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 United Arab Emirates (UAE) Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 United Arab Emirates (UAE) Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 United Arab Emirates (UAE) Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 United Arab Emirates (UAE) Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 United Arab Emirates (UAE) Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 United Arab Emirates (UAE) Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 United Arab Emirates (UAE) Buprenorphine Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Buprenorphine Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Buprenorphine Market Imports from Major Countries |
8 United Arab Emirates (UAE) Buprenorphine Market Key Performance Indicators |
9 United Arab Emirates (UAE) Buprenorphine Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Arab Emirates (UAE) Buprenorphine Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |